In addition, studies have shown that expression levels of PGC-1α, NRF1, NRF2, and TAFM are all significantly decreased in the hippocampus of AD patients, indicating that impaired mitochondrial biogenesis likely contributes to mitochondrial dysfunction in AD (Sheng et al., 2012). Here, NRF1 is linked to Alzheimer disease.